FutureChem Co.,Ltd (KOSDAQ: 220100)
South Korea
· Delayed Price · Currency is KRW
29,300
0.00 (0.00%)
Oct 14, 2024, 3:19 PM KST
FutureChem Co.,Ltd Company Description
FutureChem Co.,Ltd produces and sells radiopharmaceuticals in Korea.
The company offers PDVUE, a positron emission tomography (PET) radiopharmaceutical diagnostic medicine for Parkinson’s disease; Alzavue, a diagnostic medicine for Aalzheimer's disease; and [18F]FDG, a PET radiopharmaceutical for the treatment of cancer.
Its products in pipeline include 18F-FC303, a diagnostic PET radiopharmaceuticals for the treatment of prostate cancer; 177Lu-FC705 for the treatment of prostate cancer; 18F-FMT for the treatment of brain tumor; 18F-FC505, for the treatment of atherosclerotic plaque; and 18F-FC211, for the treatment of Alzheimer’s disease.
FutureChem Co.,Ltd was founded in 1999 and is headquartered in Seoul, South Korea.
FutureChem Co.,Ltd
Country | South Korea |
Founded | 1999 |
Industry | In Vitro and In Vivo Diagnostic Substances |
Employees | 67 |
CEO | Dae-Yoon Chi |
Contact Details
Address: 21, Yeonmujang 3-gil Seoul, 04782 South Korea | |
Phone | 82 2 497 3114 |
Website | futurechem.co.kr |
Stock Details
Ticker Symbol | 220100 |
Exchange | KOSDAQ |
Fiscal Year | January - December |
Reporting Currency | KRW |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Dae-Yoon Chi | Chief Executive Officer |